levofloxacin has been researched along with Bacterial Eye Infections in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 19 (34.55) | 29.6817 |
2010's | 31 (56.36) | 24.3611 |
2020's | 5 (9.09) | 2.80 |
Authors | Studies |
---|---|
Frings, A; Geerling, G; Goerke, P; Holtmann, C; MacKenzie, CR; Roth, M | 1 |
Dong, X; Guo, Y; Huang, C; Li, X; Wang, Z; Zhang, P | 1 |
Belov, DF; Deng, QQ; Jiang, H; Li, JL; Li, SH; Li, WJ; Luo, XQ; Nikolaenko, VP; She, TT; Wang, PD; Wang, Y; Yang, ZW | 1 |
Borde, P; Meena, AK; Parmar, GS; Prasad, S | 1 |
Huang, X; Jin, X; Lin, L; Liu, Y; Zhang, Y; Zheng, J; Zhu, B | 1 |
Inoue, Y; Matsuura, K; Miyazaki, D; Sasaki, SI; Sasaki, Y; Shimizu, Y | 1 |
Chan, CY; He, JN; Li, RX; Liu, C; Liu, SS; Niu, TT; Pang, CP; Qu, Y; Ren, CY; Wang, HL; Zhang, SD | 1 |
Alfonso, EC; Gibbons, A; Miller, D; OʼBrien, TP; Palioura, S; Spierer, O | 1 |
Moussa, K; Schallhorn, JM; Shantha, J | 1 |
Bandyopadhyay, J; Patel, T; Ting, DSJ | 1 |
Deng, Y; Huang, H; Li, S; Peng, L; Tan, Y; Wang, B; Yuan, J; Zhang, H; Zhong, J | 1 |
Darcy, K; Grzeda, M; Luck, J; Nayar, G; Tavassoli, S; Tole, D; Williams, OM | 1 |
Blanco, AR; Papa, V; Spoto, CG; Sudano Roccaro, A | 1 |
Ohashi, Y; Suzuki, T | 1 |
Allan, B; Hau, S; Robbie, SJ; Tint, NL; Vega, FA | 1 |
Hashida, M; Ohashi, Y; Okamoto, S; Shinkai, Y; Suzuki, T; Tanaka, H; Toriyama, K; Urabe, K | 1 |
Bolac, C; Brassat, S; Camus, M; Cante, V; Guillet, G; Paquier-Valette, C | 1 |
Kawasaki, S; Mitani, A; Mito, T; Ohashi, Y; Suzuki, T; Tasaka, Y; Uda, T | 1 |
Koh, S; Maeda, N; Nishida, K | 1 |
Lee, WH; Li, SA; Liu, J; Wang, YJ; Xiang, Y; Zhang, Y | 1 |
Guo, C; Han, S; Jiang, H; Liu, T; Wu, X | 1 |
Chen, DS; Hsu, HY; Sand, D; Schur, M; She, R; Shulman, IA | 1 |
Bae, SH; Jin, KW; Kim, E; Kim, H | 1 |
Fujita, K; Goto, H; Hattori, T; Ito, N; Koike, N; Kuroda, M; Matsumoto, T; Miyake, T; Tajima, K; Takahashi, H | 1 |
Gałecki, T; Lazicka-Gałecka, M; Szaflik, JP | 1 |
Aurell, S; Granstam, E | 1 |
Attisano, C; Cibinel, M; Furfaro, G; Giardini, F; Grandi, G; Grignolo, FM; Machetta, F; Panepinto, G; Pollino, C; Strani, G | 1 |
Hof, H | 1 |
Kobayakawa, S; Tochikubo, T; Tsuchiya, Y; Tsuji, A | 1 |
Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
Alekperov, SI; Boĭko, ÉV; Fokina, DV; Reĭtuzov, VA | 1 |
Galvis, V; Rey, JJ; Tello, A; Villareal, D; Wong, CA | 1 |
Chen, ZJ; Han, L; Sun, ST; Wang, LY; Yue, J; Zhang, YQ | 1 |
Fukumoto, M; Hashimoto, M; Ishida, C; Kanda, Y; Kayama, T; Kunihiro, E; Okamoto, S; Yanai, T | 1 |
Kawasaki, S; Mito, T; Ohashi, Y; Suzuki, T; Tasaka, Y; Uda, T; Uno, T | 1 |
Feng, L; Gao, Q; Huang, X; Jiang, Z; Li, Y; Lin, J; Lin, X; Liu, Y; Wang, T; Xie, Z | 1 |
Fujita, K; Hattori, T; Mori, R; Nakashizuka, H; Shimada, H; Yuzawa, M | 1 |
Chen, F; Hu, Y; Zhang, M | 1 |
Carpenter, TR; Kaufman, MB; McDonnell, PJ; Sarayba, MA; Sweet, PM; Taban, M; Tungsiripat, T | 1 |
Matoba, AY | 1 |
Hwang, DG | 1 |
Caballero, AR; Dajcs, JJ; Girgis, DO; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA | 1 |
Hasegawa, M; Kobayashi, I; Koyama, H; Matsuzaki, K; Sato, Y; Watabe, E | 1 |
Graff, JM; Kesler-Diaz, A; McDonnell, PJ; Osann, KE; Reiser, BJ; Sarayba, MA; Shamie, N; Sweet, PM; Taban, M | 1 |
Caballero, AR; Dajcs, JJ; Johnston, KH; Marquart, ME; O'Callaghan, RJ; Thibodeaux, BA | 1 |
Barry, P; Gettinby, G; Lees, F; Peterson, M; Revie, CW; Seal, DV; Wilhelmus, KR | 1 |
Barry, P; Gettinby, G; Lees, F; Peterson, M; Revie, CW; Seal, DV | 1 |
Bayar, B; Bozkurt, A; Dinçel, A; Duman, S; Kaya, E; Oflu, Y; Yağci, R; Yağci, S | 1 |
Asbell, PA; Bottone, EJ; Epstein, SP | 1 |
McDonald, MB | 1 |
Lee, PY; Liang, YB; Qiao, LY; Wan, XH; Wang, NL; Zhu, SQ | 1 |
Cantor, LB; Catoira, YP; Hoop, JS; Morgan, LS; Valluri, S; WuDunn, D; Yung, CW | 1 |
Gordon, YJ; Husted, RC; Karenchak, LM; Kowalski, RP; Pandya, AN; Ritterband, DC; Romanowski, EG; Shah, MK | 1 |
Karenchak, LM; Kowalski, RP; Mather, R; Romanowski, EG | 1 |
4 review(s) available for levofloxacin and Bacterial Eye Infections
Article | Year |
---|---|
[A review of safety and efficacy of levofloxacin 0.5% ophthalmic solution in the treatment of external ocular infections and in prophylaxis of postoperative endophthalmitis].
Topics: Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Humans; Levofloxacin; Postoperative Complications; Surgical Wound Infection | 2015 |
Listeria infections of the eye.
Topics: Animals; Anti-Bacterial Agents; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Listeria monocytogenes; Listeriosis; Moxifloxacin | 2017 |
Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Drug Resistance, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Moxifloxacin; Ofloxacin; Ophthalmology; Quinolines | 2004 |
Research review and update: IQUIX (levofloxacin 1.5%).
Topics: Animals; Anti-Bacterial Agents; Bacteria; DNA, Bacterial; Eye Infections, Bacterial; Humans; Levofloxacin; Ofloxacin; Ophthalmic Solutions; Tears; Treatment Outcome | 2006 |
5 trial(s) available for levofloxacin and Bacterial Eye Infections
Article | Year |
---|---|
[Clinical investigation of 0.3% levofloxacin eyedrops on the treatment of cases with acute bacterial conjunctivitis and bacterial keratitis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Conjunctivitis, Bacterial; Eye Infections, Bacterial; Female; Humans; Keratitis; Levofloxacin; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions | 2000 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Case for a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefuroxime; Double-Blind Method; Endophthalmitis; Eye Infections, Bacterial; Humans; Injections; Levofloxacin; Ofloxacin; Postoperative Complications; Prospective Studies | 2006 |
ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.
Topics: Administration, Topical; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Double-Blind Method; Endophthalmitis; Eye Infections, Bacterial; Humans; Injections; Levofloxacin; Ofloxacin; Phacoemulsification; Postoperative Complications; Prospective Studies | 2006 |
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.
Topics: Aged; Anterior Chamber; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Lens Implantation, Intraocular; Levofloxacin; Male; Odds Ratio; Ofloxacin; Phacoemulsification; Postoperative Complications; Prospective Studies; Risk Factors | 2007 |
Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: investigator masked, randomised clinical trial.
Topics: Administration, Oral; Anti-Bacterial Agents; Aqueous Humor; Cataract Extraction; Ciprofloxacin; Drug Therapy, Combination; Eye Infections, Bacterial; Filtering Surgery; Humans; Levofloxacin; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Single-Blind Method; Surgical Wound Infection | 2008 |
46 other study(ies) available for levofloxacin and Bacterial Eye Infections
Article | Year |
---|---|
Spectrum and resistance in bacterial infections of the ocular surface in a German tertiary referral center 2009-2019.
Topics: Anti-Bacterial Agents; Bacteria; Drug Resistance, Bacterial; Eye Infections, Bacterial; Female; Gentamicins; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Retrospective Studies; Tertiary Care Centers | 2022 |
Conjunctival sac bacterial culture of patients using levofloxacin eye drops before cataract surgery: a real-world, retrospective study.
Topics: Anti-Bacterial Agents; Cataract Extraction; Conjunctiva; Eye Infections, Bacterial; Female; Humans; Lacrimal Apparatus; Levofloxacin; Male; Microbial Sensitivity Tests; Ophthalmic Solutions; Retrospective Studies; Rifampin; Staphylococcus epidermidis | 2022 |
Topics: Anti-Bacterial Agents; Bacillaceae; Cataract; Cataract Extraction; China; Dexamethasone; Endophthalmitis; Estuaries; Eye Infections, Bacterial; Genome, Bacterial; Geologic Sediments; Humans; Levofloxacin; Phylogeny; Postoperative Complications; Povidone-Iodine; Retrospective Studies; Tobramycin | 2023 |
Microbial keratitis and antibiotic sensitivity patterns: A retrospective analysis at a tertiary center in Central India.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Erythromycin; Eye Infections, Bacterial; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Retrospective Studies | 2023 |
Characteristics of Infectious Keratitis in Bandage Contact Lens Wear Patients.
Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bandages; Contact Lenses; Corneal Ulcer; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Humans; Levofloxacin; Male; Microscopy, Confocal; Middle Aged; Retrospective Studies; Young Adult | 2019 |
Effectiveness of intraoperative iodine in cataract surgery: cleanliness of the surgical field without preoperative topical antibiotics.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacteria; Conjunctiva; Cross-Over Studies; Disinfection; DNA, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Intraoperative Period; Lens Implantation, Intraocular; Levofloxacin; Male; Phacoemulsification; Povidone-Iodine; Real-Time Polymerase Chain Reaction | 2020 |
Effectiveness of meibomian gland massage combined with topical levofloxacin against ocular surface flora in patients before penetrating ocular surgery.
Topics: Administration, Ophthalmic; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Case-Control Studies; Combined Modality Therapy; Conjunctiva; Eye Diseases; Eye Infections, Bacterial; Female; Humans; Levofloxacin; Male; Massage; Meibomian Glands; Middle Aged; Ophthalmologic Surgical Procedures; Young Adult | 2018 |
Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Corneal Ulcer; Eye Infections, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxin B; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Tobramycin; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2018 |
Blurry Vision and Eye Pain After Pterygium Surgery.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Eye Infections, Bacterial; Eye Pain; Female; Glucocorticoids; Humans; Indomethacin; Intraocular Pressure; Levofloxacin; Moxifloxacin; Ophthalmologic Surgical Procedures; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Pterygium; Scleritis; Vision Disorders; Visual Acuity | 2018 |
Microbial keratitis complicated by acute hydrops following corneal collagen cross-linking for keratoconus.
Topics: Anti-Bacterial Agents; Collagen; Corneal Edema; Corneal Pachymetry; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Dexamethasone; Drug Therapy, Combination; Eye Infections, Bacterial; Glucocorticoids; Humans; Keratoconus; Levofloxacin; Male; Photochemotherapy; Photosensitizing Agents; Riboflavin; Slit Lamp Microscopy; Staphylococcal Infections; Staphylococcus aureus; Visual Acuity; Young Adult | 2019 |
Microbiological Screening of Hypothermic Preserved Donor Corneas in Keratoplasty.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Child; Child, Preschool; Cornea; Cryopreservation; Eye Infections, Bacterial; Eye Infections, Fungal; Female; Fungi; Humans; Infant; Keratoplasty, Penetrating; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Organ Culture Techniques; Organ Preservation; Prevalence; Retrospective Studies; Risk Factors; Tissue Donors | 2019 |
An 11-year analysis of microbial keratitis in the South West of England using brain-heart infusion broth.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Brain; Cefuroxime; Corneal Ulcer; Culture Media; England; Eye Infections, Bacterial; Female; Gentamicins; Heart; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies | 2019 |
Susceptibility of methicillin-resistant Staphylococci clinical isolates to netilmicin and other antibiotics commonly used in ophthalmic therapy.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Chloramphenicol; Drug Resistance; Eye Infections, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Netilmicin; Quinolines; Staphylococcus epidermidis; Tobramycin; Vancomycin | 2013 |
Combination effect of antibiotics against bacteria isolated from keratitis using fractional inhibitory concentration index.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Cefmenoxime; Corneal Ulcer; Drug Combinations; Drug Synergism; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Pseudomonas; Quinolines; Staphylococcus; Streptococcus; Tobramycin | 2013 |
Perineural infiltrates in Pseudomonas keratitis.
Topics: Adult; Anti-Bacterial Agents; Contact Lenses, Hydrophilic; Cornea; Corneal Ulcer; Cranial Nerve Diseases; Eye Infections, Bacterial; Female; Humans; Levofloxacin; Microscopy, Confocal; Ophthalmic Nerve; Pseudomonas aeruginosa; Pseudomonas Infections | 2013 |
Prospective clinical evaluation of 1.5% levofloxacin ophthalmic solution in ophthalmic perioperative disinfection.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Female; Gram-Positive Cocci; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ophthalmic Solutions; Perioperative Care; Postoperative Complications; Prospective Studies | 2013 |
[Endogenous endophthalmitis as a complication in erysipelas].
Topics: Antifungal Agents; Bacteremia; Ceftazidime; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Therapy, Combination; Endophthalmitis; Erysipelas; Eye Infections, Bacterial; Humans; Imipenem; Intertrigo; Leg; Levofloxacin; Male; Middle Aged; Obesity; Streptococcus agalactiae; Uveitis, Anterior; Vancomycin | 2013 |
Ocular penetration and efficacy of levofloxacin using different drug-delivery techniques for the prevention of endophthalmitis in rabbit eyes with posterior capsule rupture.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Drug Delivery Systems; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Levofloxacin; Moxifloxacin; Ophthalmic Solutions; Posterior Capsular Rupture, Ocular; Rabbits; Vitreous Body | 2014 |
Visualization of the meibomian glands by means of noncontact mobile-type meibography (Meibopen) in a 16-year-old girl with unilateral marginal staphylococcal keratitis.
Topics: Administration, Oral; Administration, Topical; Adolescent; Anti-Bacterial Agents; Clarithromycin; Corneal Ulcer; Diagnostic Techniques, Ophthalmological; Drug Therapy, Combination; Eye Infections, Bacterial; Eyelid Diseases; Female; Fluorometholone; Humans; Levofloxacin; Meibomian Glands; Staphylococcal Infections; Visual Acuity | 2014 |
Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antimicrobial Cationic Peptides; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; Eye Infections, Bacterial; Gentamicins; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 2014 |
In vitro and in vivo effectiveness evaluation of balofloxacin in experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2014 |
Microbial keratitis in los angeles: the doheny eye institute and the los angeles county hospital experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Child; Ciprofloxacin; Corneal Ulcer; Eye Infections, Bacterial; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, County; Humans; Levofloxacin; Los Angeles; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies | 2015 |
Klebsiella Endophthalmitis as Retinal Vasculitis with Prostatic Abscess.
Topics: Abscess; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Humans; Intravitreal Injections; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Middle Aged; Prednisolone; Prostatic Diseases; Retinal Vasculitis; Tomography, X-Ray Computed; Visual Acuity; Vitrectomy | 2015 |
Two Different Concentrations of Topical Levofloxacin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Keratitis.
Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Keratitis; Levofloxacin; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 2015 |
Bacterial keratitis in a Swedish county hospital: management and clinical outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Child; Child, Preschool; Corneal Ulcer; Eye Infections, Bacterial; Female; Hospitals, County; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Middle Aged; Ophthalmologic Surgical Procedures; Retrospective Studies; Risk Factors; Sweden; Visual Acuity | 2016 |
Severe Ocular Bacterial Infections: A Retrospective Study Over 13 Years.
Topics: Anti-Bacterial Agents; Conjunctiva; Eye Infections, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus | 2017 |
Preventive effect against post-cataract endophthalmitis: drug delivery intraocular lens versus intracameral antibiotics.
Topics: Animals; Anterior Chamber; Anti-Bacterial Agents; Aqueous Humor; Biological Availability; Cataract Extraction; Chromatography, High Pressure Liquid; Colony Count, Microbial; Drug Delivery Systems; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacterial Infections; Lens Implantation, Intraocular; Lenses, Intraocular; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Postoperative Complications; Rabbits | 2008 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2010 |
[The effectiveness of intraocular delivery of 5-fluoroquinolones for prophylaxis of intraocular infection].
Topics: Anti-Bacterial Agents; Aza Compounds; Eye Infections, Bacterial; Eye Injuries; Female; Fluoroquinolones; Gatifloxacin; Humans; Injections, Intraocular; Levofloxacin; Male; Military Medicine; Moxifloxacin; Ofloxacin; Quinolines; Warfare | 2011 |
[In vitro antibiotic susceptibility to fluoroquinolones].
Topics: Acanthamoeba Keratitis; Anti-Bacterial Agents; Aza Compounds; Body Fluids; Ciprofloxacin; Colombia; Conjunctivitis, Bacterial; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Eye Infections, Fungal; Eye Infections, Parasitic; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies | 2012 |
[The changes of ocular bacterial isolates and in vitro antimicrobial susceptibility in the past six years].
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Eye; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus epidermidis; Tobramycin | 2012 |
Post-marketing surveillance of levofloxacin 0.5% ophthalmic solution for external ocular infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Eye Infections; Eye Infections, Bacterial; Female; Humans; Infant; Infant, Newborn; Japan; Levofloxacin; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Product Surveillance, Postmarketing; Treatment Outcome; Young Adult | 2012 |
Moxifloxacin as postoperative prophylaxis for Enterococcus faecalis-induced endophthalmitis after cataract surgery in aphakic rabbits.
Topics: Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Aphakia, Postcataract; Aza Compounds; Disease Models, Animal; Electroretinography; Endophthalmitis; Enterococcus faecalis; Eye Infections, Bacterial; Fluoroquinolones; Gram-Positive Bacterial Infections; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Phacoemulsification; Quinolines; Rabbits; Time Factors | 2013 |
A preliminary study to treat severe endophthalmitis via a foldable capsular vitreous body with sustained levofloxacin release in rabbits.
Topics: Animals; Anti-Bacterial Agents; Ciliary Body; Colony Count, Microbial; Cytokines; Drug Delivery Systems; Drug Implants; Endophthalmitis; Eye Infections, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rabbits; Real-Time Polymerase Chain Reaction; RNA, Messenger; Staphylococcal Infections; Staphylococcus epidermidis; Vitreous Body | 2013 |
Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.
Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Conjunctiva; Endophthalmitis; Eye Infections, Bacterial; Humans; Intravitreal Injections; Levofloxacin; Masks; Povidone-Iodine; Ranibizumab; Retrospective Studies; Therapeutic Irrigation; Vascular Endothelial Growth Factor A | 2013 |
Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Keratitis; Keratomileusis, Laser In Situ; Levofloxacin; Ofloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Surgical Flaps | 2003 |
Polymicrobial keratitis secondary to Burkholderia ambifaria, enterococcus, and staphylococcus aureus in a patient with herpetic stromal keratitis.
Topics: Amikacin; Burkholderia; Burkholderia Infections; Corneal Stroma; Drug Therapy, Combination; Enterococcus; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Keratitis, Herpetic; Levofloxacin; Male; Middle Aged; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Quantitative comparison of fluoroquinolone therapies of experimental gram-negative bacterial keratitis.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Cornea; Eye Infections, Bacterial; Fluoroquinolones; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Serratia Infections; Serratia marcescens | 2004 |
[Antimicrobial susceptibility surveillance of recent isolates from ophthalmological infections to gatifloxacin and other antimicrobial drugs].
Topics: Anti-Infective Agents; Drug Resistance, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Quinolones | 2005 |
Fluoroquinolone therapy in Mycobacterium chelonae keratitis after lamellar keratectomy.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Cornea; Corneal Transplantation; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Keratitis; Levofloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ofloxacin; Rabbits | 2005 |
Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Ofloxacin; Ophthalmic Solutions; Quinolines; Rabbits | 2006 |
Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Ciprofloxacin; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Levofloxacin; Moxifloxacin; Ofloxacin; Ophthalmic Solutions; Quinolines; Rabbits; Staphylococcal Infections; Vitreous Body | 2007 |
Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections.
Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines | 2006 |
Penetration of topically applied levofloxacin into eyes with thin-wall filtering bleb after trabeculectomy.
Topics: Adult; Aged; Anti-Bacterial Agents; Aqueous Humor; Cataract Extraction; Eye Infections, Bacterial; Female; Filtering Surgery; Humans; Intraocular Pressure; Levofloxacin; Male; Middle Aged; Ofloxacin; Trabeculectomy | 2008 |
An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Microbial; Eye Infections, Bacterial; Humans; Keratitis; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus aureus; Time Factors | 2001 |
Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Retrospective Studies | 2002 |